Related Experiment Videos
Summary
A mild fever during isoniazid (INH) prophylaxis can signal a severe reaction upon re-administration. This case highlights that initial mild reactions to INH are critical warnings for potentially life-threatening rechallenge events.
Area of Science:
- Pharmacology
- Clinical Medicine
- Adverse Drug Reactions
Background:
- Isoniazid (INH) is a primary medication for tuberculosis prevention and treatment.
- Drug-induced fever is a known, though infrequent, adverse effect of many medications.
- Prophylactic use of INH is common in individuals at risk for tuberculosis.
Observation:
- A patient experienced a mild febrile reaction two weeks after initiating INH prophylaxis.
- Following discontinuation, the patient was later rechallenged with INH.
- Upon rechallenge, the patient developed a severe febrile reaction accompanied by prolonged hypotension.
Findings:
- An initial mild febrile reaction to isoniazid is a significant predictor of a severe adverse event upon subsequent exposure.
- Rechallenge with isoniazid after an initial mild reaction can precipitate a serious and potentially fatal hypersensitivity response.
- Protracted hypotension was a key feature of the severe reaction observed.
Implications:
- Clinicians must be vigilant for even mild febrile reactions during INH therapy, as they may indicate a risk for severe hypersensitivity.
- The findings underscore the importance of careful patient monitoring during and after INH prophylaxis.
- This case emphasizes that a history of even a mild reaction to INH warrants extreme caution or alternative treatment strategies.